Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)

Universidade do Porto65 enrolled

Overview

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

Retrospective observational study based on analyzing the first 48 hours of the multimodal neuromonitoring signal, from spontaneous ICH patients, whose treatment includes invasive intraparenchymal neuromonitoring, treated from January 2015 to September 2021 in a tertiary hospital.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Intracerebral Hemorrhage Critically Ill Intracranial Pressure Cerebral Perfusion Pressure Prognostic

Interventions

Multimodal NeuromonitoringDIAGNOSTIC_TEST

Invasive Multimodal Neuromonitoring

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Spontaneous Intracerebral Hemorrhage * ICU admission * Need of Sedation and Ventilatory Support * Need of Intracerebral Neuromonitoring Exclusion Criteria: * Etiology for Intracerebral hemorrhage such as tumor, vascular malformation, ischemic transformation.

Locations (1)

Centro Hospitalar Universitário de São João

Porto, Portugal

Outcomes

Primary Outcomes

Survival

1 and 6 months survival

Time frame: 1 and 6 months

Functional Outcome

6 month functional outcome with Modified Rankin Scale - 0 (No symptoms); 1 (No significant disability); 2 (Slight disability); 3 (Moderate disability); 4 (Moderately Severe Disability); 5 (Severe Disability); 6 (Dead).

Time frame: 6 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.